Pauline Williams, Head of Global Health R&D, GSK
Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
- GSK data presented at ERS further supports its industry-leading respiratory medicines portfolio
- GSK announces results of indirect treatment comparisons of Nucala to benralizumab and reslizumab for severe eosinophilic asthma
Tweets from GSK
-
GSK @GSK
Sara Latham, COO @COPDFoundation explains why it’s important for patient organisations to attend scientific meetings, such as #ERSCongress @COPDGlobal
about 2 hours ago -
GSK @GSK
Successful management goals for #severeasthma patients - experts discuss at #ERSCongress #ERS2018
about 6 hours ago
-
GSK @GSK
This evening at #ERSCongress we heard from experts in respiratory on the challenges of treating patients with #severeasthma. #ERS2018
about 18 hours ago
